0001104659-21-011108.txt : 20210202 0001104659-21-011108.hdr.sgml : 20210202 20210202200154 ACCESSION NUMBER: 0001104659-21-011108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210131 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sender Gary CENTRAL INDEX KEY: 0001659085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 21583676 MAIL ADDRESS: STREET 1: C/O SYNERGY PHARMACEUTICALS INC. STREET 2: 420 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm215099-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-01-31 0 0001641640 Nabriva Therapeutics plc NBRV 0001659085 Sender Gary 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Chief Financial Officer Ordinary Shares 2021-01-31 4 F 0 37 2.62 D 20503 D /s/ Robert Crotty, by power of attorney 2021-02-02